about
Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha responseRotavirus vaccines: development and use for the prevention of diarrhoeal disease.Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy.Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in miceAn oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic piRotavirus disease and its prevention in infants and children.Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particlesSerum IgG mediates mucosal immunity against rotavirus infectionUse of the baculovirus expression system for the generation of virus-like particles.Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.Ebola virus-like particles protect from lethal Ebola virus infection.Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.Advances in virus-like particle vaccines for filoviruses.Rotavirus virus-like particles administered mucosally induce protective immunity.Baculovirus as a highly efficient expression vector in insect and mammalian cells.A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamianaImmunogenicity of HGV NS5 protein expressed from Sf9 insect cells.Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like ParticlesTransfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector.Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease.Insect cells as a production platform of complex virus-like particles.Bioengineering virus-like particles as vaccines.New approaches in oral rotavirus vaccines.Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques.Hydrophilicity dependent budding and secretion of chimeric HIV Gag-V3 virus-like particles.Synthesis of rotavirus-like particles in insect cells: comparative and quantitative analysis.Effect of MOI ratio on the composition and yield of chimeric infectious bursal disease virus-like particles by baculovirus co-infection: deterministic predictions and experimental results.Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography.Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in miceGamma-irradiated rotavirus: A possible whole virus inactivated vaccine.Production of complex virus-like particles in insect cells
P2860
Q33598425-B7B15EAA-0916-4898-99C6-F5AEF24273ADQ33603410-C8B7B506-A6D9-48B3-ACED-B32C9BFFE424Q33604018-55F99D77-48FD-4501-9A99-54CF9EAA34C9Q33649962-C8294691-8292-4F60-90A2-562348135588Q33690975-0B0E6D5C-A029-422C-99D5-CDF206A7581AQ33717736-AF01FE3D-16A9-4A4E-B8F6-9A72A2E96A5EQ33725133-BF9DF9FF-D163-47CB-84A4-D3880709B421Q33771355-FD42C66A-81F5-4AFA-A5BF-F2298764B3BBQ33782483-8FB8F6DC-3B05-4777-8D97-1D6E52CD1C84Q33785446-92905814-27F4-4847-BA81-F254933ED68FQ33813867-46A862BC-5FCC-463B-9B16-52B0A4BD5416Q33821665-CA4179F7-7EF3-4EFA-8F64-1730D4804AF6Q34351909-0AC11E61-812A-4426-B100-5996ECEA266DQ34357038-784B90A4-7C0B-4692-AE16-623988A9087AQ34792924-45D89203-BD3D-4106-BCF2-DF03AC3E2B06Q35202880-E3A823D6-4AD5-4BD2-BE74-201A6D9F968CQ35300029-15C9ECCF-25AC-43BC-8DD8-E35DE7472CBAQ35898882-F84C5528-B330-4D24-A225-DD0EE7EE3749Q36075878-6E1316B6-BC2A-4499-B3D9-DA7FCB780AEAQ36149102-1E116182-7189-4D7D-ABF6-12438A5D73C7Q36210208-AC618E3F-B261-4A27-8E8A-984090C213A3Q36340900-3CC5D046-AB25-4F69-8648-F08F8E2FD147Q36397357-9B644E91-CFDA-4676-ADE8-280C6F6DB4C1Q36845999-4355AA78-C3BC-487C-B454-CB31A60B5173Q37516075-7CF30E5A-03DA-43C6-A4CF-C930E4787D13Q37691015-0C183917-7E5E-4558-AFEB-6A1E6DF9A9D2Q38081968-85FE7F46-E8FA-4150-9EB3-19ED9ECA6A6CQ38081976-D1DC196F-5F9D-4AC0-A14C-DACD53C3F266Q38172045-DEA02835-9B68-46E0-B4AB-BFD0BFF009ECQ38255552-C77AB059-8BED-493C-9E92-34FB4CECB71FQ38840884-4FA562D9-BAA8-44D7-AD57-28D41F8FBFFBQ40131145-9C24A1E2-2A15-48FF-8E2E-56B9C4D53D38Q40963427-861045AF-3953-4F8E-8C0A-B1391EC85B71Q42053410-D85599D2-5448-4364-B78D-D15C94675B0AQ42058392-20290098-3F87-4388-B48A-3203B2D7C35DQ42628113-82EB42F3-EED4-4433-B624-C2367A98B03BQ55405177-32265C6C-0E2E-4416-9BDF-7FC514E070DEQ58753726-10DC68CA-F685-43B8-B30B-74104D7D91AD
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Virus-like particles as a rotavirus subunit vaccine.
@en
type
label
Virus-like particles as a rotavirus subunit vaccine.
@en
prefLabel
Virus-like particles as a rotavirus subunit vaccine.
@en
P2093
P1476
Virus-like particles as a rotavirus subunit vaccine
@en
P2093
C D Zarley
D Drabinski
H P Madore
M E Conner
S Crawford
P304
P356
10.1093/INFDIS/174.SUPPLEMENT_1.S88
P407
P478
174 Suppl 1
P577
1996-09-01T00:00:00Z